Indication
Epithelial Ovarian Carcinoma Stage IV
1 clinical trial
1 product
Clinical trial
Nab-paclitaxel Versus Solvent-based Taxanes As First-Line Treatment for Patients With Advanced Ovarian CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Nab-Paclitaxel + Carboplatin